Miconazole Nitrate

Athletes Foot Liquid


Walgreens Company
Human Otc Drug
NDC 0363-4208
Miconazole Nitrate also known as Athletes Foot Liquid is a human otc drug labeled by 'Walgreens Company'. National Drug Code (NDC) number for Miconazole Nitrate is 0363-4208. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Miconazole Nitrate drug includes Miconazole Nitrate - 3 g/150g . The currest status of Miconazole Nitrate drug is Active.

Drug Information:

Drug NDC: 0363-4208
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Miconazole Nitrate
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Athletes Foot Liquid
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Walgreens Company
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Spray
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:MICONAZOLE NITRATE - 3 g/150g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 18 May, 2010
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 15 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333C
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Walgreens Company
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:998533
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0311917113425
UPC stands for Universal Product Code.
UNII:VW4H1CYW1K
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:Azole Antifungal [EPC]
Azoles [CS]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
0363-4208-53150 g in 1 CAN (0363-4208-53)18 May, 2010N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

?purpose antifungal

Product Elements:

Miconazole nitrate athletes foot liquid acetone diethylene glycol monoethyl ether propylene glycol alcohol .alpha.-tocopherol acetate miconazole nitrate miconazole

Indications and Usage:

Uses cures most athlete's foot (linea pedis), ringworm (linea corporis) and jock itch (linea cruris) relieves symptoms of athlete's foot, including itching burning and cracking

Warnings:

Warnings for external use only. extremely flammable: do not use while smoking or near heat or flame. do not puncture or incinerate, contents under pressure. do not store at temperature above 120ºf. when using this product avoid contact with the eyes or mouth use only as directed intentional misuse by deliberately concentrating and inhaling contents cans be harmful or fatal. ?stop use and ask a doctor if no improvement within 4 weeks for athlete's foot and ringworm; 2 weeks for jock itch irritation occurs ?keep out of reach of children. if swallowed, get medical help or contact a poison control center right away. do not use on children under 2 years of age unless directed by a doctor.

When Using:

When using this product avoid contact with the eyes or mouth use only as directed intentional misuse by deliberately concentrating and inhaling contents cans be harmful or fatal.

Dosage and Administration:

?directions wash affected area and dry thoroughly shake can well and spray a thin layer over affected area twice daily (morning and night) or as directed by a doctor supervise children in the use of this product for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily for athlete's foot and ringworm, use daily for 4 weeks; for jock itch, use daily for 2 weeks if conditions persist, consult a doctor this product is not effective on the scalp or nails

Stop Use:

?stop use and ask a doctor if no improvement within 4 weeks for athlete's foot and ringworm; 2 weeks for jock itch irritation occurs

Package Label Principal Display Panel:

?principal display panel well at walgreens medicated • antifungal athlete's foot liquid spray miconazole nitrate 2% cures & prevents most athlete's foot relieves itching and burning net wt 5.3 oz (150g) wal af mic nit spray can.jpg

Further Questions:

? ?questions? call 1-866-964-0939


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.